Global Immune Technologies Inc. (GIMU) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
2809 GREAT NORTHERN LOOP, STE 100 MISSOULA, MT 59808-1749 |
| State of Incorp. | |
| Fiscal Year End | March 31 |
| Industry (SIC) | 10 - Metal Mining (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2013 Q2 | 6/30/2013 Q1 | 3/31/2013 Q4 | 12/31/2012 Q3 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 13 | 134 | 117 | 20 | ||
| Cash and cash equivalents | 13 | 134 | 117 | 20 | ||
| Receivables | 2 | 1 | 1 | |||
| Total current assets: | 14 | 135 | 118 | 20 | ||
| Noncurrent Assets | ||||||
| Other undisclosed noncurrent assets | 83 | 18 | ||||
| Total noncurrent assets: | 83 | 18 | ||||
| TOTAL ASSETS: | 97 | 153 | 118 | 20 | ||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities, including: | 224 | 248 | 245 | 232 | ||
| Other undisclosed accounts payable and accrued liabilities | 224 | 248 | 245 | 232 | ||
| Debt | 65 | 65 | 33 | |||
| Due to related parties | 418 | 418 | 418 | 906 | ||
| Other undisclosed current liabilities | 39 | 172 | 173 | |||
| Total current liabilities: | 746 | 903 | 868 | 1,137 | ||
| Noncurrent Liabilities | ||||||
| Total liabilities: | 746 | 903 | 868 | 1,137 | ||
| Equity | ||||||
| Equity, attributable to parent, including: | (649) | (750) | (750) | (1,117) | ||
| Common stock | 4,561 | 4,309 | 4,078 | 3,548 | ||
| Accumulated other comprehensive income | 5 | 5 | 5 | 5 | ||
| Accumulated deficit | (5,064) | (4,833) | (4,670) | |||
| Other undisclosed equity, attributable to parent | (5,214) | |||||
| Total equity: | (649) | (750) | (750) | (1,117) | ||
| TOTAL LIABILITIES AND EQUITY: | 97 | 153 | 118 | 20 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 9/30/2013 Q2 | 6/30/2013 Q1 | 3/31/2013 Q4 | 12/31/2012 Q3 | ||
|---|---|---|---|---|---|
| Operating expenses | (0) | (0) | 22 | (24) | |
| Other undisclosed operating loss | (143) | (231) | (185) | (173) | |
| Operating loss: | (143) | (231) | (162) | (197) | |
| Nonoperating income (expense) (loss, Foreign Currency Transaction, before Tax) | (16) | ||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (8) | ||||
| Loss from continuing operations: | (159) | (231) | (171) | (197) | |
| Loss before gain (loss) on sale of properties: | (159) | (231) | (171) | (197) | |
| Net loss: | (159) | (231) | (171) | (197) | |
| Other undisclosed net income attributable to parent | 16 | 8 | |||
| Net loss available to common stockholders, diluted: | (143) | (231) | (162) | (197) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2013 Q2 | 6/30/2013 Q1 | 3/31/2013 Q4 | 12/31/2012 Q3 | ||
|---|---|---|---|---|---|
| Net loss: | (159) | (231) | (171) | (197) | |
| Comprehensive loss, net of tax, attributable to parent: | (159) | (231) | (171) | (197) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.